Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification
- Type
- Retraction
- Notice date
- 10/4/2023 0:00
- Journal
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9782478
- Original paper DOI
- 10.1155/2022/5702014
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions